STAT+: Pharmalittle: CDC director overrules panel and recommends Pfizer shot for at-risk workers; DOD watchdog faults military over pharma supply chain issues
And so, another working week will soon draw to a close. Not a moment too…
Category: pharmalittle
STAT+: Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales
Top of the morning to you, and a fine one, it is. Delicious cool breezes…
STAT+: Pharmalittle: Pharma lobbies Congress on global tax proposal; the FDA doc at center of Aduhelm controversy
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Biogen’s ‘symptom quiz’ for Aduhelm draws fire; most U.S. clinical trials flunk transparency rules
Good morning. Elizabeth Cooney sitting in for Ed Silverman on what from here looks like…
STAT+: Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa
Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping…
.jpg)
STAT+: Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: Pfizer seeks full FDA approval for its Covid-19 vaccine; CT attorney general calls some Sacklers ‘entitled thugs’
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Lilly seeks speedy U.S. approval for its Alzheimer’s drug; FDA’s Woodcock ‘not concerned’ about criticism
Hello, everyone, and nice to see you again after a day off. We can explain…
STAT+: Pharmalittle: Inside the FDA’s contentious Aduhelm approval; Peter Bach heading to liquid biopsy startup
Good morning! Elizabeth Cooney here, sitting in for Ed Silverman, who would no doubt be…
STAT+: Pharmalittle: How Pfizer’s Covid vaccine boxes complicated rollout; FDA and J&J near deal to reopen vaccine plant
Good morning! Elizabeth Cooney sitting in for Ed Silverman today as he gets an early…
STAT+: Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Lilly fired manager who tracked employee production complaints; Denmark suspends AstraZeneca shot
Top of the morning to you, and a fine one it is. We say this…
STAT+: Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal
Rise and shine, another busy day is on the way. We can tell it is…
STAT+: Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine
Good morning, one and all. Damian Garde here, filling in for Ed Silverman in the…
STAT+: Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Top of the morning to you. Another busy day is unfolding here on the Pharmalot…
STAT+: Pharmalittle: GSK to partner with CureVac on Covid-19 vaccine; Jazz to buy GW Pharma in $7.2 billion deal
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
STAT+: Pharmalittle: Russia’s Covid-19 vaccine appears effective; BioCryst stock is pursued by Reddit investors
Rise and shine, everyone, another busy day is on the way. Once again, however, events…
STAT+: Pharmalittle: FDA finds Moderna vaccine effective; Trump drug discount card gets new life
Hello, everyone, and how are you today? We are doing just fine, thank you. A…
STAT Plus: Pharmalittle: Operation Warp Speed is more Army than science; J&J’s Covid-19 vaccine moves forward
Good morning, one and all. Damian Garde here, filling in for Ed Silverman at the…
STAT Plus: Pharmalittle: In political ploy, Trump promises drug coupons to seniors; N.Y. plans its own Covid-19 vaccine reviews
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?
Good morning. Elizabeth Cooney here, taking the wheel from Ed Silverman today as we ponder…
STAT Plus: Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering
Good morning, everyone. Damian Garde here, filling in for Ed Silverman in the waning hours…
STAT Plus: Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
And so, another working week will soon come to an end. Not a moment too…
STAT Plus: Pharmalittle: Groups backed by pharma oppose equitable Covid-19 pricing; AstraZeneca strikes big Covid-19 vaccine deal
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: France piles pressure on Sanofi over Covid-19 vaccine; GOP fails to land a punch on Bright
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients
And so, another working week will soon draw to a close. This may be hard…
STAT Plus: Pharmalittle: Novartis to test hydroxycholoroquine in Covid-19; malaria drug failed to protect lupus patients from coronavirus
Good morning, everyone, and welcome to another working week. We hope the weekend offered something…
STAT Plus: Pharmalittle: Early data suggests Gilead Covid-19 drug works; did FDA drop standards too far in hunt for chloroquine?
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: More than one coronavirus vaccine may be needed; Utah bill would protect docs prescribing meds for Covid-19
Hello, everyone, and how are you today? We are coping, thank you, despite the ongoing…
STAT Plus: Pharmalittle: Docs ask states for lethal injection drugs to combat Covid-19; Raw material costs for hydroxycholorquine slow production
Good morning, everyone, and how are you today? We are doing all right, under the…
STAT Plus: Pharmalittle: India to ramp up ingredients production; CIA warns employees about taking hydroxycholoroquine
Rise and shine, everyone, another challenging day is on the way. We can tell because…
STAT Plus: Pharmalittle: Gilead Covid-19 drug shows early promise; AstraZeneca halts trial due to ‘overwhelming’ benefit
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT Plus: Pharmalittle: Poison control sees more cases after Trump touts malaria drug; Indian companies to double hydroxychloroquine output
And so, another working week will soon come to a close. Not a moment too…
STAT Plus: Pharmalittle: More clinical trials derailed by Covid-19; Pfizer jumpstarts tests on a drug to fight the pandemic
Rise and shine, everyone, another challenging day is on the way. And while it will…
STAT Plus: Pharmalittle: India to allow limited exports of malaria drug; some Trump allies profit if hydroxychloroquine is approved
Good morning, everyone, and how are you today? As the saying goes, stay on the…
STAT Plus: Pharmalittle: States try to prevent hoarding of drug used for Covid-19; is BARDA ready for the coronavirus?
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Pharmalittle: Sanofi poised to supply millions of doses of malaria drug; Roche unit apologizes for ‘Wuhan’ virus label
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Pharmalittle: Novartis scraps generic sale to Aurobindo; another small study suggests old malaria drug works
Rise and shine, everyone, another busy day is on the way. How could it be…
STAT Plus: Pharmalittle: U.S. asks India to list restrictions on pharma ingredients; Giuliani wants FDA to fast-track a drug for Covid-19
Good morning, everyone, and welcome to the middle of the week. Given that so many…
STAT Plus: Pharmalittle: A TB vaccine is tested against the coronavirus; FDA doesn’t punish Novartis over data integrity scandal
Hello, everyone, and how are you coping this morning? We are doing just fine, thank…
STAT Plus: Pharmalittle: Drug pricing legislation is on the back burner; FDA issues emergency use for old malaria drugs
Good morning, everyone, and welcome to another working week, although it may not quite seem…
STAT Plus: Pharmalittle: Conservative group pushes for malaria drug approval for Covid-19; OTC drug industry to get an overhaul
And so, another working week will soon come to a close. Not a moment too…
STAT Plus: Pharmalittle: Gilead asks FDA to rescind orphan status for Covid-19 drug; Bristol delays MS drug launch due to coronavirus
Good morning, everyone, and how are you today? We hope you are finding ways to…
STAT Plus: Pharmalittle: Scientists say coronavirus is not mutating significantly; WHO is asked to pool Covid-19 patent rights
Hello, everyone, and welcome to the middle of the week. Under the circumstances, this is…
STAT Plus: Pharmalittle: Pharmacy boards limit prescriptions for drugs touted by Trump; Nearly half of trial sites expect disruptions
Hello, everyone, and how are you this morning? Despite the chaos, we are hanging in…